← FDA ENFORCEMENT
D-0140-2024Class III
Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop
Recalling firm
Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop
Product type
Drug
Status
Terminated
Report date
2023-12-13
Distribution
USA Nationwide
Firm state
TX
Product quantity
190 syringes
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Documentation & Change ControlReason for recall
Product Mix-up: Incorrect Product Formulation
Product description
LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1
Code / lot info
Lot#: 09202023@7, Exp 03/18/2024
Other recalls SPEQ maps to Documentation & Change Control
See all Documentation & Change Control recalls →Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.